SPOTLIGHT -
Slideshow
Author(s):
Which of these agents best prevents relapse? A recent study employed a novel approach to find out.
Clinical Pearls: Treating Trauma and Psychosis
Here's to a Psychedelic Revolution
Peter J. Weiden, MD, Discusses Clozapine REMS Challenges and Advisory Committees' Recommendations
Treating ‘Morally Objectionable’ Patients
FDA Committees Vote to Dismiss Clozapine REMS
Beyond Dopamine: Muscarinic Solutions Bring New Hope for Schizophrenia